416 related articles for article (PubMed ID: 18669458)
1. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
[TBL] [Abstract][Full Text] [Related]
2. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
Le Tourneau C; Michiels S; Gan HK; Siu LL
J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
[TBL] [Abstract][Full Text] [Related]
3. Improvement in the quality of randomized controlled trials among general anesthesiology journals 2000 to 2006: a 6-year follow-up.
Greenfield ML; Mhyre JM; Mashour GA; Blum JM; Yen EC; Rosenberg AL
Anesth Analg; 2009 Jun; 108(6):1916-21. PubMed ID: 19448222
[TBL] [Abstract][Full Text] [Related]
4. Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application.
Duff JM; Leather H; Walden EO; LaPlant KD; George TJ
J Natl Cancer Inst; 2010 May; 102(10):702-5. PubMed ID: 20410466
[TBL] [Abstract][Full Text] [Related]
5. The quality of reporting and outcome measures in randomized clinical trials related to upper-extremity disorders.
Gummesson C; Atroshi I; Ekdahl C
J Hand Surg Am; 2004 Jul; 29(4):727-34; discussion 735-7. PubMed ID: 15249101
[TBL] [Abstract][Full Text] [Related]
6. Reporting of safety results in published reports of randomized controlled trials.
Pitrou I; Boutron I; Ahmad N; Ravaud P
Arch Intern Med; 2009 Oct; 169(19):1756-61. PubMed ID: 19858432
[TBL] [Abstract][Full Text] [Related]
7. Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals.
Lai TY; Wong VW; Lam RF; Cheng AC; Lam DS; Leung GM
Ophthalmic Epidemiol; 2007; 14(6):390-8. PubMed ID: 18161613
[TBL] [Abstract][Full Text] [Related]
8. Chinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journals.
Xu L; Li J; Zhang M; Ai C; Wang L
Contemp Clin Trials; 2008 Sep; 29(5):727-31. PubMed ID: 18579449
[TBL] [Abstract][Full Text] [Related]
9. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.
Tang PA; Bentzen SM; Chen EX; Siu LL
J Clin Oncol; 2007 Oct; 25(29):4562-8. PubMed ID: 17876010
[TBL] [Abstract][Full Text] [Related]
10. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals.
Berwanger O; Ribeiro RA; Finkelsztejn A; Watanabe M; Suzumura EA; Duncan BB; Devereaux PJ; Cook D
J Clin Epidemiol; 2009 Apr; 62(4):387-92. PubMed ID: 19010643
[TBL] [Abstract][Full Text] [Related]
11. The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?
Gravel J; Opatrny L; Shapiro S
Clin Trials; 2007; 4(4):350-6. PubMed ID: 17848496
[TBL] [Abstract][Full Text] [Related]
12. Reporting adverse events in randomized controlled trials.
Nuovo J; Sather C
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):349-51. PubMed ID: 16998947
[TBL] [Abstract][Full Text] [Related]
13. Determining the reporting quality of RCTs in clinical pharmacology.
Mills E; Loke YK; Wu P; Montori VM; Perri D; Moher D; Guyatt G
Br J Clin Pharmacol; 2004 Jul; 58(1):61-5. PubMed ID: 15206994
[TBL] [Abstract][Full Text] [Related]
14. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals.
Thakur A; Wang EC; Chiu TT; Chen W; Ko CY; Chang JT; Atkinson JB; Fonkalsrud EW; Grosfeld JL
J Pediatr Surg; 2001 Aug; 36(8):1160-4. PubMed ID: 11479847
[TBL] [Abstract][Full Text] [Related]
15. Assessing quality of reports on randomized clinical trials in nursing journals.
Parent N; Hanley JA
Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement.
Ziogas DC; Zintzaras E
Ann Epidemiol; 2009 Jul; 19(7):494-500. PubMed ID: 19523596
[TBL] [Abstract][Full Text] [Related]
17. Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT).
Smith BA; Lee HJ; Lee JH; Choi M; Jones DE; Bausell RB; Broome ME
Nurs Outlook; 2008; 56(1):31-37. PubMed ID: 18237622
[TBL] [Abstract][Full Text] [Related]
18. Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
Ohorodnyk P; Eisenhauer EA; Booth CM
Eur J Cancer; 2009 Sep; 45(13):2249-52. PubMed ID: 19545996
[TBL] [Abstract][Full Text] [Related]
19. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
[TBL] [Abstract][Full Text] [Related]
20. An analysis of general medical and specialist journals that endorse CONSORT found that reporting was not enforced consistently.
Mills E; Wu P; Gagnier J; Heels-Ansdell D; Montori VM
J Clin Epidemiol; 2005 Jul; 58(7):662-7. PubMed ID: 15939216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
